SCHEMBL9301070

SCHEMBL9301070

C=C1CCN(C(P(=O)(O)O)P(=O)(O)OCC)CC1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FDPS P14324 3/20 0.37
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301258 0.86 FDPS (0.38) FDPSTSHR
SCHEMBL6670360 0.85 FDPS (0.45) FDPSTSHR
SCHEMBL5075884 0.85 FDPS (0.45) FDPSTSHR
SCHEMBL9301453 0.84 FDPS (0.36) FDPSTSHR
SCHEMBL9302173 0.83 FDPS (0.37) FDPS
SCHEMBL9303056 0.81 FDPS (0.34) FDPS
SCHEMBL22991420 0.81 POLB (0.33) TSHR
SCHEMBL9301316 0.80 FDPS (0.56) FDPS
SCHEMBL9301175 0.79 FDPS (0.33) FDPS
SCHEMBL9302643 0.77 FDPS (0.38) FDPSTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350743-A Treatment of osteoporosis KAKEN PHARMACEUTICAL CO., LTD. (JP) 1994-09-27 US disclosed
EP-0498424-A1 Bisphosphonic acid derivatives and bone resorption inhibitors containing them Kaken Pharmaceutical Co., Ltd. (JP) 1992-08-12 EP disclosed